Table 4.

Point estimates of vitamin A deficiency assessed using retinol-binding protein and inflammation assessed using C-reactive protein and Alpha-1-acid glycoprotein.

Biomarkers	n	Prevalence % (95% CI)
		0.43 µmol/L		0.7 µmol/L
Unadjusted RBP	1100	2 (1; 4)		24 (20; 29)
BRINDA adjusted RBP	1100	0 (0; 1)		10 (7; 14)
Inflammation Criteria
	n		% (95% CI)
Total	1100		57 (52; 63)
Incubation stage	14		1 (0; 2)
Early stage	264		23 (19; 28)
Late stage	372		33 (29; 37)

RBP: Retinol Binding Protein. Inflammation was defined as: normal (CRP < 5 mg/L and AGP < 1.0 g/L), incubation (CRP > 5 mg/L and AGP < 1.0 g/L), early convalescence (CRP > 5 mg/L and AGP > 1.0 g/L), and late convalescence (CRP < 5 mg/L and AGP > 1.0 g/L).